Diamond; Betty A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Diamond; Betty A..The latest application filed is for "c1q and hmgb1 fusion proteins and uses thereof".

Company Profile

3.10.14

Diamond; Betty A. - Bronx NY
Diamond; Betty A. - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies Grant 11,365,243 - Diamond , et al. June 21, 2	2022-06-21
C1q AND HMGB1 FUSION PROTEINS AND USES THEREOF App 20220089644 - Diamond; Betty A.	2022-03-24
C1q and HMGB1 fusion proteins and uses thereof Grant 11,168,112 - Diamond November 9, 2	2021-11-09
Inhibition Of Autism Spectrum Disorder Using Decoy Antigens To Maternal Brain-reactive Antibodies App 20200247880 - Kind Code	2020-08-06
Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies Grant 10,654,919 - Diamond , et al.	2020-05-19
C1q AND HMGB1 FUSION PROTEINS AND USES THEREOF App 20190169232 - Diamond; Betty A.	2019-06-06
Inhibition Of Autism Spectrum Disorder Using Decoy Antigens To Maternal Brain-reactive Antibodies App 20190040121 - Diamond; Betty A. ; et al.	2019-02-07
C1q peptides and uses thereof Grant 9,758,557 - Diamond September 12, 2	2017-09-12
Compounds and methods for treatment of systemic lupus erythematosus Grant 9,096,576 - Al-Abed , et al. August 4, 2	2015-08-04
C1q PEPTIDES AND USES THEREOF App 20150104472 - Diamond; Betty A.	2015-04-16
Compounds And Methods For Treatment Of Systemic Lupus Erythematosus App 20140309255 - Al-Abed; Yousef ; et al.	2014-10-16
Compounds and methods for treatment of systemic lupus erythematosus Grant 8,741,924 - Al-Abed , et al. June 3, 2	2014-06-03
Methods For Treating Systemic Lupus Erythematosus Using Hiv Protease Inhibitors App 20130317040 - Al-Abed; Yousef ; et al.	2013-11-28
Compounds And Methods For Treatment Of Systemic Lupus Erythematosus App 20130123299 - Al-Abed; Yousef ; et al.	2013-05-16
Peptides for detecting anti-double stranded DNA antibody and uses thereof Grant 7,517,657 - Gaynor , et al. April 14, 2	2009-04-14
Treatment of Cognitive Dysfunction in Lupus App 20070231316 - Diamond; Betty A. ; et al.	2007-10-04
Methods and compositions for identification of antigen-specific B cell populations App 20050287607 - Diamond, Betty A. ; et al.	2005-12-29
Peptides for the treatment and diagnosis of systemic lupus erythematosus App 20050214852 - Gaynor, Bruce D. ; et al.	2005-09-29
Peptides for the treatment and diagnosis of systemic lupus erythematosus Grant 6,932,970 - Gaynor , et al. August 23, 2	2005-08-23
Hybridoma-producing NSO myeloma cell line Grant 5,565,337 - Diamond , et al. October 15, 1	1996-10-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.